Adolescent gender dysphoria: What is the evidence for medical interventions

Adolescent gender dysphoria: What is the evidence for medical interventions is organized by The Royal Society of Medicine (RSM) and will be held on Jul 02, 2021 at The Royal Society of Medicine, London, England, United Kingdom.

Description:
This meeting will explore the evidence for intervention with medical hormonal therapy in adolescents with gender dysphoria and the effects of this approach. 

The use of gonadotropin-releasing hormone (GnRH) agonists (more commonly known as hormone or puberty blockers) in transgender adolescents is a contentious topic in regards to the ethics of treating children, evidence-based medicine and long term effects.

The early use of blockers has been suggested as reversible but as treatment of this group increases, issues and challenges in regards to fertility preservation and the effects of future gender reassignment surgery, cognitive and bone health have been highlighted.

This area is very controversial, in society and medical practice, with a judicial review ongoing together with a NICE Review of Evidence. In addition, there is a High Court Case challenging the Gillick Competency in adolescents.

This meeting will provide a balanced and informed debate into the current practice affecting medical practitioners from urology, gynaecology, endocrinology and psychiatry.

Topics include:
• The evidence for medical intervention in adolescent dysphoria
• Highlight and understand the controversies in this area
• The roles of all gender identity specialists in adolescent dysphoria
• Provide a template for future research and management in this challenging area